NasdaqGS - Delayed Quote USD
NextCure, Inc. (NXTC)
At close: 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
22,378.0000
Operating Expense
63,664.0000
67,637.0000
75,909.0000
70,765.0000
63,603.0000
Operating Income
-63,664.0000
-67,637.0000
-75,909.0000
-70,765.0000
-41,225.0000
Other Income Expense
2,385.0000
4,914.0000
1,176.0000
1,376.0000
4,622.0000
Pretax Income
-61,279.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Net Income Common Stockholders
-61,279.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Diluted NI Available to Com Stockholders
-61,279.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Basic EPS
-2.28
-2.25
-2.69
-2.51
-1.33
Diluted EPS
-2.28
-2.25
-2.69
-2.51
-1.33
Basic Average Shares
27,868.7100
27,836.5840
27,744.2090
27,615.9770
27,532.1770
Diluted Average Shares
27,868.7100
27,836.5840
27,744.2090
27,615.9770
27,532.1770
Total Operating Income as Reported
-66,206.0000
-67,637.0000
-75,909.0000
-70,765.0000
-41,225.0000
Total Expenses
63,664.0000
67,637.0000
75,909.0000
70,765.0000
63,603.0000
Net Income from Continuing & Discontinued Operation
-61,279.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Normalized Income
-58,737.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
EBIT
-63,664.0000
-67,637.0000
-75,909.0000
-70,765.0000
-41,225.0000
EBITDA
-60,403.0000
-63,953.0000
-71,785.0000
-66,588.0000
-37,812.0000
Reconciled Depreciation
3,261.0000
3,684.0000
4,124.0000
4,177.0000
3,413.0000
Net Income from Continuing Operation Net Minority Interest
-61,279.0000
-62,723.0000
-74,733.0000
-69,389.0000
-36,603.0000
Total Unusual Items Excluding Goodwill
-2,542.0000
--
--
--
--
Total Unusual Items
-2,542.0000
--
--
--
--
Normalized EBITDA
-57,861.0000
-63,953.0000
-71,785.0000
-66,588.0000
-37,812.0000
12/31/2020 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASMB Assembly Biosciences, Inc.
17.59
-5.02%
SEER Seer, Inc.
1.9800
+0.51%
GLTO Galecto, Inc.
6.71
-0.45%
ACHL Achilles Therapeutics plc
0.9900
+1.08%
CTMX CytomX Therapeutics, Inc.
1.1800
+5.36%
TBPH Theravance Biopharma, Inc.
8.70
+1.16%
GLPG.AS Galapagos NV
27.00
-0.59%
ANTX AN2 Therapeutics, Inc.
1.0600
+0.95%
BOLT Bolt Biotherapeutics, Inc.
0.6400
+1.59%
SPRO Spero Therapeutics, Inc.
1.2400
+3.33%